Question 1

What is Journey Medical Corp (DERM) stock price today?

Accepted Answer

Journey Medical Corp (DERM) currently trades at $5.15 per share. The stock has a market capitalization of $171.27M and a P/E ratio of —x.

Question 2

Is DERM stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Journey Medical Corp has a Smart Value Score of 29/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Journey Medical Corp's revenue and earnings?

Accepted Answer

Journey Medical Corp has trailing twelve-month (TTM) revenue of $61.86M with profit margins of -18.50%. Earnings per share (EPS) is $-0.47.

Question 4

Is DERM stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Journey Medical Corp's intrinsic value is $9.48, representing a margin of safety of 15.72%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$73.67M	$79.18M	$56.13M	$61.86M	$61.86M
Net income	$-29.63M	$-3.85M	$-14.67M	$-11.43M	$-1.25M
EPS	—	—	—	—	$-0.47
Free cash flow	$-33.53M	$240000.00	$-24.13M	$-12.44M	$-6.36M
Profit margin	-40.22%	-4.87%	-26.14%	-18.48%	-18.50%

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DERM	$171.27M	29	4.7	2.0	6.0	5.0	+15.72%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Journey Medical Corp

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare